title: Why a breast boost should remain a controversial aspect of routine breast conservation management in Australia and New Zealand in 2002.
abstract: Two randomized trials have recently shown a statistically significant improvement in local control when a boost is employed in the conservative treatment of early breast cancer. However, unresolved issues of cost effectiveness, potentially increased toxicity and the inability to automatically generalize these results to Australian and New Zealand practice remain. In view of these unresolved controversies, the St George and Wollongong hospitals breast boost trial (SGW trial) will continue to recruit.
authors.affiliation: Cancer Care Centre, St George Hospital, Kogarah, New South Wales, Australia. GrahamP@sesahs.nsw.gov.au
authors.forename: P
authors.initials: P
authors.lastname: Graham
authors.forename: A
authors.initials: A
authors.lastname: Capp
authors.forename: C
authors.initials: C
authors.lastname: Fox
authors.forename: E
authors.initials: E
authors.lastname: Nasser
authors.forename: G
authors.initials: G
authors.lastname: Delaney
authors.forename: V
authors.initials: V
authors.lastname: Ahern
authors.forename: C
authors.initials: C
authors.lastname: Wratten
mesh_terms: D000368:Aged; D001315:Australia; D001943:Breast Neoplasms / Q000532:radiotherapy*; D004307:Dose-Response Relationship, Radiation; D005060:Europe; D005260:Female; D006801:Humans; D009520:New Zealand; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic